Trinity Biotech
TRIB
23 hedge funds and large institutions have $589K invested in Trinity Biotech in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 8 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
13% less capital invested
Capital invested by funds: $673K → $589K (-$84.4K)
15% less funds holding
Funds holding: 27 → 23 (-4)
31.9% less ownership
Funds ownership: 37.64% → 5.73% (-32%)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YAG
Yorkville Advisors Global
Mountainside,
New Jersey
|
+$166K |
| 2 |
VF
Virtu Financial
New York
|
+$19.6K |
| 3 |
WN
Williams & Novak
Westlake Village,
California
|
+$10.6K |
| 4 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
+$7.06K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$14.8K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$12.5K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10.5K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.98K |
| 5 |
Renaissance Technologies
New York
|
-$1.84K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$10.5K | -14,249 | Closed |
|
|
27
Osaic Holdings
Scottsdale,
Arizona
| – | -$1.98K | -2,500 | Closed |
|
28
Bank of America
Charlotte,
North Carolina
| – | -$867 | -1,095 | Closed |
|
29
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$791 | -1,000 | Closed |
|
30
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -1,000 | Closed |
|
31
Fidelity Investments
Boston,
Massachusetts
| – | -$9 | -11 | Closed |
|
TRIB Hedge Fund Activity: Q1 2026 in Review
23 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q1 2026, worth a combined $589K — down 13% from $673K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of TRIB and 5 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 4 added.
The largest buyer was Yorkville Advisors Global, opening a new position worth an estimated $166K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $14.8K sold.
- 23 institutional investors held Trinity Biotech (TRIB) as of Q1 2026, down from 27 in Q4 2025.
- Funds reported $589K of Trinity Biotech stock for Q1 2026, down 13% quarter-over-quarter.
- 5 funds opened new Trinity Biotech positions in Q1 2026 and 8 closed out, a net change of -3 holders.
- The largest Trinity Biotech buyer in Q1 2026 was Yorkville Advisors Global, an estimated $166K added.
- The largest Trinity Biotech seller in Q1 2026 was Two Sigma Investments, an estimated $14.8K sold.
Based on aggregated 13F filings for Q1 2026.